Santhera Report issue

For profit Phase 1 Phase 2 Phase 4
Founded: Liestal Switzerland (2004)
Status: Acquired by Biovail (2009) → now Bausch Health Companies (2010)

Organization Overview

First Clinical Trial
2005
NCT00654784
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

SANTHERA PHARMA | Santhera Pharmaceuticals